Release Date: 2024-06-10

The “Golden Spice” Curcuma Longa L. and Curcuminoids

Etil Guzelmeric (Author)

Release Date: 2024-06-10

The vibrant, yellow to orange-colored dried rhizomes of Curcuma longa L. (turmeric) have been used for centuries as a spice, especially in Chinese and Indian cuisines. This powder is regarded as “Golden spice” due to its wide range of health benefits. Experimental and clinical studies have revealed that the compounds found in rhizomes of turmeric, [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inMedicinal Spices
    First Page15
    Last Page31
    DOIhttps://doi.org/10.69860/nobel.9786053359340.2
    Page Count17
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

    The vibrant, yellow to orange-colored dried rhizomes of Curcuma longa L. (turmeric) have been used for centuries as a spice, especially in Chinese and Indian cuisines. This powder is regarded as “Golden spice” due to its wide range of health benefits. Experimental and clinical studies have revealed that the compounds found in rhizomes of turmeric, especially curcuminoids, are mainly responsible for its pharmacological activities such as antioxidant, immunomodulatory, anti-inflammatory, hepatoprotective, and anticancer.

    Etil Guzelmeric (Author)
    Associate Professor, Yeditepe University
    https://orcid.org/0000-0001-9696-3271
    3Etil Güzelmeriç completed her doctorate in 2015 at Yeditepe University, Faculty of Pharmacy, Department of Pharmacognosy. Then, she was appointed as an assistant professor in this department. She has been working as an associate professor since 2022. Her areas of expertise are chromatographic analyses and bioactivity studies of medicinal plants and bee products.

    • Balasubramanian S, Mohite AM, Singh KK, Zachariah TJ, and Anand T. Physical properties of turmeric (Curcuma longa L.). Journal of Spices and Aromatic Crops. 2012;21(2):178-181.

    • Prasad S, Aggarwal B. Turmeric, the Golden Spice. Herbal medicine: Biomolecular and clinical aspects, CRC Press, Taylor & Francis, 2018.

    • Khalandar SD., Adithya TN., Basha SJ, Koshma M, Subbareddy UV, Reddy, VA. Current review on Curcuma longa Linn. Plant. International Journal of Pharmaceutical, Chemical and Biological Sciences. 2018;8(1):68-73.

    • Iweala EJ, Uche ME, Dike ED, Etumnu LR, Dokunmu TM, Oluwapelumi AE, Okoro BC, Dania OE, Adebayo AH, and Ugbogu EA. Curcuma longa (Turmeric): Ethnomedicinal uses, phytochemistry, pharmacological activities and toxicity profiles-A review. Pharmacological Research-Modern Chinese Medicine. 2023;6:100222.

    • Lee WH, Loo CY, Bebawy M, Luk F, Mason RS, and Rohanizadeh R. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Current Neuropharmacology. 2013;11(4):338-378

    • Trujillo J, Chirino YI, Molina-Jijón E, Andérica-Romero AC, Tapia E, and Pedraza-Chaverrí J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biology. 2013;1(1):448-456.

    • Dosoky NS and Setzer WN. Chemical Composition and Biological Activities of Essential Oils of Curcuma Species. Nutrients. 2018;10(9):1196.

    • Dosoky NS, Satyal P, and Setzer WN. Variations in the volatile compositions of Curcuma species. Foods. 2019;8(2):53.

    • Singhal S, Hasan N, Nirmal K, Chawla R, Chawla S, Kalra BS, and Dhal A. Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol. Trials. 2021;22:1-11.

    • Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Cesarone MR, Hosoi M, and Errichi M. Meriva (R)+ glucosamine versus condroitin+ glucosamine in patients with knee osteoarthritis: An observational study. European Review for Medical and Pharmacological Science. 2014;18(24):3959-3963.

    • Amalraj A, Varma K, Jacob J, Divya C, Kunnumakkara AB, Stohs SJ, and Gopi S. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. Journal of Medicinal Food. 2017;20(10):1022-1030.

    • Daily JW, Yang M, and Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. Journal of Medicinal Food. 2016;19(8):717-729.

    • Thamlikitkul V, Bunyapraphatsara N, Dechatiwongse T, Theerapong S, Chantrakul C, Thanaveerasuwan T, Nimitnon S, Boonroj P, Punkrut W, and Gingsungneon V. Randomized double blind study of Curcuma domestica Val. for dyspepsia. Journal of the Medical Association of Thailand= Chotmaihet Thangphaet. 1989;72(11):613-620.

    • ⦁ Yongwatana K, Harinwan K, Chirapongsathorn S, Opuchar K, Sanpajit T, Piyanirun W, and Puttapitakpong C. Curcuma longa Linn versus omeprazole in treatment of functional dyspepsia: A randomized, double‐blind, placebo‐controlled trial. Journal of Gastroenterology and Hepatology. 2022;37(2):335-341.

    • Kongkam P, Khongkha W, Lopimpisuth C, Chumsri C, Kosarussawadee P, Phutrakool P, Khamsai S, Sawanyawisuth K, Sura T, Phisalprapa P, Buamahakul T, Siwamogsatham S, Angsusing J, Poonniam P, Wanaratna K, Teerachaisakul M, and Pongpirul K. Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial. BMJ Evidence-Based Medicine. 2023;28(6):399-406.

    • Khonche A, Biglarian O, Panahi Y, Valizadegan G, Soflaei SS, Ghamarchehreh ME, Majeed M, and Sahebkar A. Adjunctive therapy with curcumin for peptic ulcer: a randomized controlled trial. Drug Research. 2016;66(8):444-448.

    • Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M,Yamada M, Iwaıka Y, Kane K, Hiraishi H, Hirayama K, Arai H, Yoshii S, Uchijima M, Nagata T, and Koide, Y. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology. 2006;4(12):1502-1506.

    • Chandan S, Mohan BP, Chandan OC, Ahmad R, Challa A, Tummala H, Singh S, Dhawan P, Ponnada S, Singh AB, and Adler DG. Curcumin use in ulcerative colitis: is it ready for prime time? A systematic review and meta-analysis of clinical trials. Annals of Gastroenterology. 2020;33(1):53.

    • Kim SW, Ha KC, Choi EK, Jung SY, Kim MG, Kwon DY, Yang HJ, Kim MJ, Kang HJ, Back HI, Kim SY, Park SH, Baek HY, Kim YJ, Lee JY, and Chae SW. The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study. BMC Complementary and Alternative Medicine. 2013;13:1-8.

    • Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, and Sahebkar A. Treatment of non‐alcoholic fatty liver disease with curcumin: A randomized placebo‐controlled trial. Phytotherapy Research. 2016;30(9):1540-1548.

    • Yang YS, Su YF, Yang HW, Lee YH, Chou JI, and Ueng KC. Lipid‐lowering effects of curcumin in patients with metabolic syndrome: a randomized, double‐blind, placebo‐controlled trial. Phytotherapy Research. 2014;28(12):1770-1777.

    • Yuan F, Dong H, Gong J, Wang D, Hu M, Huang W, Fang K, Qin X, Yang X, and Lu F. A systematic review and meta-analysis of randomized controlled trials on the effects of turmeric and curcuminoids on blood lipids in adults with metabolic diseases. Advances in Nutrition. 2019;10(5):791-802.

    • Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, and Sahebkar A. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis. Clinical Nutrition. 2015;34(6):1101-1108.

    • Na LX, Yan BL, Jiang S, Cui HL, Li Y, and Sun CH. Curcuminoids target decreasing serum adipocyte-fatty acid binding protein levels in their glucose-lowering effect in patients with type 2 diabetes. Biomedical and Environmental Science. 2014;27(11):902-906.

    • Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G, and Ghayour-Mobarhan M. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial. Chinese Journal of Integrative Medicine.2015;21:332-338.

    • Bergman J, Miodownik C, Bersudsky Y, Sokolik S, Lerner PP, Kreinin A, Polakiewicz J, and Lerner V. Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Clinical Neuropharmacology. 2013;36(3):73-77.

    • Panahi Y, Badeli R, Karami GR, and Sahebkar A. Investigation of the efficacy of adjunctive therapy with bioavailability‐boosted curcuminoids in major depressive disorder. Phytotherapy Research. 2015;29(1):17-21

    • Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, Martinez J, Wong KP, Liu J, Merrill DA, Chen ST, Henning SM, Satyamurthy N, Huang SC, Heber D, and Barrio JR. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: a double-blind, placebo-controlled 18-month trial. The American Journal of Geriatric Psychiatry. 2018;26(3):266-277.

    • Antiga E, Bonciolini V, Volpi W, Del Bianco E, and Caproni M. Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris. BioMed Research International. 2015;2015:283634.

    • Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, and Morrow GR. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiation Research. 2013;180(1):34-43.

    • Gorabi AM, Razi B, Aslani S, Abbasifard M, Imani D, Sathyapalan T, and Sahebkar A. Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials. Cytokine. 2021;143:155541.

    • Anand P, Kunnumakkara AB, Newman RA, and Aggarwal BB. Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics. 2007;4(6):807-818.

    • ESCOP 2003:ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products. 2nd Edition, Thieme, 2003.

    • Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, and Brenner DE. Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine. 2006;6(1):10.

    • Aggarwal BB, Kumar A, and Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research. 2003;23(1/A):363-398.

    • Capasso F. Phytotherapy: A quick reference to herbal medicine. Springer Science and Business Media, 2003.

    • Kim DC, Ku SK, and Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Reports. 2012;45(4):221-226.

    onix_3.0::thothThoth ONIX 3.0
    onix_3.0::project_museProject MUSE ONIX 3.0
    onix_3.0::oapenOAPEN ONIX 3.0
    onix_3.0::jstorJSTOR ONIX 3.0
    onix_3.0::google_booksGoogle Books ONIX 3.0
    onix_3.0::overdriveOverDrive ONIX 3.0
    onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
    csv::thothThoth CSV
    json::thothThoth JSON
    kbart::oclcOCLC KBART
    bibtex::thothThoth BibTeX
    doideposit::crossrefCrossRef DOI deposit
    onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
    marc21record::thothThoth MARC 21 Record
    marc21markup::thothThoth MARC 21 Markup
    marc21xml::thothThoth MARC 21 XML

    Share This Chapter!